| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | herpes simplex virus 1 antibody (IgG), HSV1 antibody (IgG) |
| Assay Time | |
| Assay Type | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum |
| Species | |
| Target |
Background
herpes simplex virus Ⅰ (HSVⅠ) antibody (IgG) (HSVⅠ Ab (IgG)) is a biological molecule commonly studied in microbiology research. Immunoglobulins are antibody proteins central to humoral immunity and antigen-specific responses.
Biological context
Researchers often monitor herpes simplex virus Ⅰ (HSVⅠ) antibody (IgG) in serum to better understand themes such as infection and host defense, pathogen-associated inflammatory responses, and microbial–host interactions. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in herpes simplex virus Ⅰ (HSVⅠ) antibody (IgG) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, host-response mediators, barrier markers, and pathogen-associated immune readouts) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, herpes simplex virus Ⅰ (HSVⅠ) antibody (IgG) may also appear under names such as herpes simplex virus 1 antibody (IgG), HSV1 antibody (IgG). When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that herpes simplex virus Ⅰ (HSVⅠ) antibody (IgG) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Preclinical and clinical evaluation of intratumoral injection of an IL-12 expressing SKV-012 oncolytic virus for advanced solid tumors
Z Jiang, N Yang, J Jin, Z Zhang, H Lu,Journal for Immunotherapy of Cancer,2025
Herpes simplex virus type I–infected disorders alter the balance between Treg and Th17 cells in recurrent herpes labialis patients
XX Mei,International Journal of Immunopathology and Pharmacology,2020